跳至主要内容
临床试验/NCT03635918
NCT03635918Unknown不适用

Extensive Prospective Validation Study of the NightOwl Home Sleep Apnea Test

Ectosense NV2 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2018年8月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
500
试验地点
2
主要终点
Apnea-Hypopnea Index (AHI)

研究概览

简要总结

Extensive Prospective validation study of the NightOwl, a Type IV home sleep apnea test (HSAT), compared to traditional PSG and HSAT monitors.

详细描述

The purpose of this prospective validation study is the evaluation of the accuracy of the NightOwl HSAT to derive parameters relevant for the diagnosis of sleep apnea. The NightOwl HSAT comprises a finger or forehead mounted sensor and an automated analytics software. The sensor measures double-wavelength photo-plethysmography and accelerometry. The analytics software automatically interprets the sensor data and derives a measure of sympathetic activation of the autonomic nervous system, oxygen saturation, instantaneous pulse rate and activity. For each patient in the cohort, the AHI derived by the NightOwl will be compared to that of the Type I sleep monitor (in-lab PSG), which will acquire data simultaneously during the diagnostic night of the patient referred to the sleep lab for a polysomnography. On a randomly selected subset of patients, a benchmark HSAT will additionally be applied for comparison of its automated AHI derivation to that of the NightOwl.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • indication for a sleep study

排除标准

  • Mentally disabled people

研究组 & 干预措施

NightOwl HSAT

Other

Patient undergoes a NightOwl sleep apnea test whilst simultaneously undergoing a sleep study with a Type I sleep monitor (Lab-PSG) and optionally a benchmark HSAT monitor.

干预措施: NightOwl HSAT (Device)

结局指标

主要结局

Apnea-Hypopnea Index (AHI)

时间窗: For each included patient, the outcome measure will be assessed immediately after analysis of that patient's data by the NightOwl HSAT software

Comparison of the AHI derived from the NightOwl HSAT to that of the benchmark PSG and HSAT monitors.

次要结局

  • Sleep-wake discrimination(For each included patient, the outcome measure will be assessed immediately after analysis of that patient's data by the NightOwl HSAT software)

研究者

发起方
Ectosense NV
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Extensive Prospective Validation Study of the... | 临床试验